SURGICAL DERMATOLOGY Experience Commitment Compassion
Dr. William Ting is a skilled dermatologic and reconstructive surgeon and is a fellow of the American Society of Dermatologic Surgery. He has tremendous experience in surgical and procedural dermatology. He has completed a surgically-oriented dermatology residency at the University of Iowa where he operated on countless Iowan farmers and families with skin cancers on face and neck as well as other parts of the body. As a result, at the end of his dermatology residency, he had substantially greater amount of surgical experience than a typical dermatology graduate in the U.S.
He had acquired significant Mohs micrographic surgery experience while working with Drs. Duane Whitaker, Christopher Arpey and Daniel Davis while at University of Iowa. Given his extensive surgical experience with Iowan farmers with skin cancers during Dermatology Residency and his desire to manage the entire spectrum of the field of dermatology, Dr. Ting decided not to pursue a fellowship under American College of Mohs Surgery. Dr. William Ting has performed more than fifteen hundred Mohs micrographic surgery and countless reconstructive surgeries for non-melanoma skin cancer since year 2000. Dr Ting is a member of American Society for Mohs Surgery as are 48% of Mohs surgeons in California.
Dr. Ting is at the forefront of dermatologic surgery by being the first physician in the East Bay and the first dermatologic surgeon in Northern California to pioneer the revolutionary FDA-approved CelluLaze surgical laser therapy for cellulite of thighs. Dr. Ting is proud to be the first dermatologist in the San Francisco Bay Area to introduce Cutera GenesisPlus Laser for post surgical laser scar revision. Both hypertrophic surgical scar and associated redness can be effectively treated with Cutera GenesisPlus Laser.
Hypertrophic surgical scar and associated redness after Mohs surgery on nose treated by Cutera GenesisPlus
Hypertrophic surgical scar and associated redness after Mohs surgery on right upper lip treated by Cutera GenesisPlus
His skill in tumescent liposuction arose from his apprenticeship with Dr. Jeffrey Klein, who invented and published numerous peer-reviewed medical articles on tumescent liposuction.
Dr. Ting has become one of the early pioneers of fractional CO2 laser resurfacing. With his Electrical Engineering undergraduate background at UC Berkeley and understanding of the laser optics, he has mastered the subtleties of cosmetic and therapeutic lasers, particularly fractional CO2 laser enabling him to expertly deliver the most optimal resurfacing for patients who need to reverse years of photoaging and acne scarring.
Common Surgical Dermatology Procedures:
- Laser surgery for scar revision and laser resurfacing
- Curettage and electrodessication
- Reconstruction including flap and graft repairs
- Subcision for scar revision
Advanced Surgical Dermatology Procedures:
- Mohs Surgery for non-melanoma skin cancers
- SmartLipo Laser Body Sculpting and Tumescent Liposuction
- CelluLaze Surgical Laser Cellulite Therapy
FACTOIDS about SKIN CANCER
Skin cancers can be minimized via strict daily sun protection, regular visits to a board-certified dermatologist and modalities to reverse sun damage (see Preventive Dermatology page)
- 1 in 3 Caucasian-Americans will have a nonmelanoma skin cancer (NMSC) in his or her lifetime.
- Basal cell carcinoma (BCC) derives from malignant proliferation of the bottom layer of the epidermis, known as the basal layer. It is the most common skin cancer, period, for Caucasian-Americans.
- Squamous cell carcinoma (SCC) arises from malignant proliferation of the top layers of the epidermis. It is the second most common NMSC, tends to be more aggressive and grows more quickly than BCC. More than 10% of SCC may metastasize if left untreated for several months.
- Malignant Melanoma is triggered by malignant transformation of pigment-producing cells of the epidermis known as melanocytes.
- Risk of melanoma is 1 in 33 Americans in year 2007/8.
- Invasive melanoma is the 6th most common cancer in men and women.
- Melanoma is the second most common cancer for women aged 20-29 years.
- 5-year survival of melanoma-in-situ, if caught early, is better than 95%.
- Every first-degree relative of someone with history of melanoma must get a head-to-toes skin check once a year as the risk of melanoma is significantly higher than the general population.
- Click for MORE Magazine’s article on ‘What you need to know about Malignant melanoma’.